RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
  Emergency Medicine
  Internal Medicine
  Respiratory Medicine
   Cystic Fibrosis
  Sexual Medicine
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
COPD Channel

subscribe to COPD newsletter
Latest Research : Medicine : Respiratory Medicine : COPD

   EMAIL   |   PRINT
Women with chronic obstructive pulmonary disease (COPD) fare worse than men

Jun 12, 2006 - 8:02:00 PM , Reviewed by: Sanjukta Acharya
"Women's life expectancy is on average seven years longer than men's, so women who are living with a chronic illness like COPD will bear a heavier burden of disease compared with men."

[RxPG] Women with chronic obstructive pulmonary disease (COPD) fare worse than men both in terms of the severity of their disease and their quality of life. These differences may play a role in the increased death rate seen among female patients with COPD, said researcher Claudia Cote, M.D., Assistant Professor of Medicine at the University of South Florida in Tampa.

The researchers studied 85 women, and compared them with 95 men who had the same levels of COPD severity according to guidelines of the Global Initiative for Chronic Lung Disease (GOLD). They found that female patients were significantly younger than male patients with the same severity of disease. The women had lower lung function, more trouble breathing, and reported a worse quality of life. The women also received a worse score on the BODE index, which looks at lung function, nutritional status, symptoms and exercise capacity in order to measure a COPD patient's disease severity and predicted survival.

COPD is the fourth leading cause of death in America, claiming the lives of 120,000 Americans in 2002. Beginning in 2000, women have exceeded men in the number of deaths attributable to COPD. In 2002, over 61,000 females died compared with 59,000 males.

Reasons that women with COPD do worse than their male counterparts, Dr. Cote said, may be related to underdiagnosis, misdiagnosis and less access to healthcare.

While the study findings may appear discouraging for women with COPD, the way in which the patients were assessed can lead to improvements in treatment for all COPD patients, Dr. Cote said.

"Until recently, doctors have used only lung function as a measurement for COPD severity," Dr. Cote said. "But we've come a long way in understanding this disease, and we now know that while COPD affects the respiratory system, it also has tremendous consequences on the peripheral muscles, cardiovascular system, and overall nutritional status--it's a multi-systemic disease. If we only measure respiratory function we will be overlooking other organ impairment and then will miss an opportunity for intervention."

Understanding that COPD can affect many aspects of a patient's health gives doctors more tools to treat patients, Dr. Cote said. "Traditionally, doctors have just looked at airflow obstruction, which doesn't respond well to drug treatment and has the tendency to deteriorate as a person ages, so the disease has seemed poorly treatable and minimally reversible. But by doing a comprehensive assessment, looking at a patient's nutritional status, exercise capacity and symptoms, it becomes more possible to treat COPD because such impairment is amenable to intervention."

For example, she said, there are now two long-acting bronchodilators that have been shown to improve not only lung function but also exercise capacity, symptoms, health status and lung hyperinflation in COPD patients. Non-drug interventions such as pulmonary rehabilitation can also improve some of these outcomes and improve survival, while surgery such as lung volume reduction and lung transplantation greatly help selected patients while prolonging their lives. "We should see COPD as a treatable disease and be aggressive in the management of our patients. Maybe then we'll be able to impact survival," she said. "COPD no longer has to be seen as a chronic, relentless, and fatal disease--we can help patients live longer with better quality of life."

This message is important for women in particular, Dr. Cote said. "Women's life expectancy is on average seven years longer than men's, so women who are living with a chronic illness like COPD will bear a heavier burden of disease compared with men."

There is a growing awareness that COPD is treatable, and that there are tools to assess how patients are doing on many levels, Dr. Cote said. "Physicians will start treating COPD more aggressively, because they know they can provide important improvements in outcomes for their patients."

Publication: American Thoracic Society International Conference
On the web: www.thoracic.org 

Advertise in this space for $10 per month. Contact us today.

Related COPD News
New genetic variants for COPD discovered in a groundbreaking study by SpiroMeta Consortium
Mediterranean diet halves risk of progressive lung disease
COPD patients using beta-agonist inhalers are at risk
Beta-agonists more than double death rate in COPD patients
Lung function test underused in patients with COPD
Wrinkles clue to risk of progressive lung disease (COPD)
Antibiotics reduce risk of dying from COPD attack by 77 percent
Women with chronic obstructive pulmonary disease (COPD) fare worse than men
Breathing Heliox 28 significantly improve the exercise performance in COPD
Combined treatment cuts inflammatory cells in chronic obstructive pulmonary disease

Subscribe to COPD Newsletter

Enter your email address:

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)